NI200300001A - Nelfinavir COMPRESSED DOSAGE AND METHOD FOR INCREASED manufacture. - Google Patents
Nelfinavir COMPRESSED DOSAGE AND METHOD FOR INCREASED manufacture.Info
- Publication number
- NI200300001A NI200300001A NI200300001A NI200300001A NI200300001A NI 200300001 A NI200300001 A NI 200300001A NI 200300001 A NI200300001 A NI 200300001A NI 200300001 A NI200300001 A NI 200300001A NI 200300001 A NI200300001 A NI 200300001A
- Authority
- NI
- Nicaragua
- Prior art keywords
- nelfinavir
- compressed dosage
- mixture
- increased manufacture
- mechanical energy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Glanulating (AREA)
Abstract
UN COMPRIMIDO DE NELFINAVIR DE DOSIS ELEVADA QUE TIENE UNA RELACION EN PESO DE NELFINAVIR DE DOSIS ELEVADA SE FABRICAN EN UN RPOCEDIMEINTO EN EL QUE SE FORMA UNA MEZCLA GRANULADA DE UN COMPUESTO DE NELFINAVIR Y UN AGLUTINANTE, EN UN PROCEDIMIENTO DE GRANULACION, Y A CONTINUACION SE ELABORA PARA FORMAR LOS COMPRIMIDOS. EN EL PROCEDIMIENTO DE GRANULACION SE AÑADE HUMEDAD Y SE APLICA ENERGIA MECANICA A LA MEZCLA, Y LA MEZCLA SE CURA SIN ADICION DE HUMEDAD O APLICACIÓN DE ENERGIA MECANICA.A NELFINAVIR ELEVATED DOSE TABLET THAT HAS A RELATIONSHIP IN ELEVATED DOSE NELFINAVIR WEIGHT IS MANUFACTURED IN A RPOCEDIMEINTO IN WHICH A GRANULATED MIXTURE OF A NELFINAVIR COMPOUND AND A BINDING PROCESS IS MADE, IN A PROCEDURE TO FORM THE TABLETS. IN THE GRANULATION PROCEDURE MOISTURE IS ADDED AND MECHANICAL ENERGY IS APPLIED TO THE MIXTURE, AND THE MIXTURE IS CURE WITHOUT ADDITION OF HUMIDITY OR APPLICATION OF MECHANICAL ENERGY.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35142002P | 2002-01-28 | 2002-01-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NI200300001A true NI200300001A (en) | 2004-12-21 |
Family
ID=27663002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NI200300001A NI200300001A (en) | 2002-01-28 | 2003-01-07 | Nelfinavir COMPRESSED DOSAGE AND METHOD FOR INCREASED manufacture. |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1469836A1 (en) |
| JP (1) | JP2005521661A (en) |
| KR (1) | KR20040079952A (en) |
| CN (1) | CN1713895A (en) |
| AR (1) | AR038236A1 (en) |
| BR (1) | BR0307190A (en) |
| CA (1) | CA2398226A1 (en) |
| GT (1) | GT200300016A (en) |
| HN (1) | HN2003000048A (en) |
| HU (1) | HUP0500512A2 (en) |
| IL (1) | IL162724A0 (en) |
| MX (1) | MXPA04007237A (en) |
| NI (1) | NI200300001A (en) |
| NO (1) | NO20043238L (en) |
| NZ (1) | NZ533283A (en) |
| PA (1) | PA8564301A1 (en) |
| PE (1) | PE20030730A1 (en) |
| PL (1) | PL373882A1 (en) |
| RU (1) | RU2004123206A (en) |
| SV (1) | SV2004001467A (en) |
| TW (1) | TW200302111A (en) |
| WO (1) | WO2003063837A1 (en) |
| ZA (1) | ZA200404367B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008053276A1 (en) * | 2006-10-30 | 2008-05-08 | Collette Nv | Transition piece for the transfer of powder or granular material from a discharge opening to a conveying line and method of transferring powder or granular material |
| AU2007358602A1 (en) * | 2007-09-03 | 2009-03-12 | Lucent Technologies Inc. | Method and system for checking automatically connectivity status of an IP link on IP network |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6499984B1 (en) * | 2000-05-22 | 2002-12-31 | Warner-Lambert Company | Continuous production of pharmaceutical granulation |
| MXPA03009971A (en) * | 2001-05-03 | 2004-02-12 | Hoffmann La Roche | Pharmaceutical dosage form of amorphous nelfinavir mesylate. |
-
2002
- 2002-08-15 CA CA002398226A patent/CA2398226A1/en not_active Abandoned
-
2003
- 2003-01-07 NI NI200300001A patent/NI200300001A/en unknown
- 2003-01-16 NZ NZ533283A patent/NZ533283A/en unknown
- 2003-01-16 WO PCT/IB2003/000117 patent/WO2003063837A1/en not_active Ceased
- 2003-01-16 EP EP03700070A patent/EP1469836A1/en not_active Withdrawn
- 2003-01-16 BR BR0307190-1A patent/BR0307190A/en not_active IP Right Cessation
- 2003-01-16 MX MXPA04007237A patent/MXPA04007237A/en unknown
- 2003-01-16 HU HU0500512A patent/HUP0500512A2/en unknown
- 2003-01-16 RU RU2004123206/15A patent/RU2004123206A/en not_active Application Discontinuation
- 2003-01-16 KR KR10-2004-7011562A patent/KR20040079952A/en not_active Ceased
- 2003-01-16 JP JP2003563531A patent/JP2005521661A/en active Pending
- 2003-01-16 CN CNA038028360A patent/CN1713895A/en active Pending
- 2003-01-16 PL PL03373882A patent/PL373882A1/en not_active Application Discontinuation
- 2003-01-16 IL IL16272403A patent/IL162724A0/en unknown
- 2003-01-24 PE PE2003000074A patent/PE20030730A1/en not_active Application Discontinuation
- 2003-01-27 AR ARP030100228A patent/AR038236A1/en unknown
- 2003-01-27 SV SV2003001467A patent/SV2004001467A/en not_active Application Discontinuation
- 2003-01-27 TW TW092101739A patent/TW200302111A/en unknown
- 2003-01-27 HN HN2003000048A patent/HN2003000048A/en unknown
- 2003-01-28 GT GT200300016A patent/GT200300016A/en unknown
- 2003-01-28 PA PA20038564301A patent/PA8564301A1/en unknown
-
2004
- 2004-06-03 ZA ZA200404367A patent/ZA200404367B/en unknown
- 2004-08-02 NO NO20043238A patent/NO20043238L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20043238L (en) | 2004-08-02 |
| CA2398226A1 (en) | 2003-07-28 |
| RU2004123206A (en) | 2005-04-20 |
| PA8564301A1 (en) | 2003-09-05 |
| GT200300016A (en) | 2003-09-11 |
| HUP0500512A2 (en) | 2005-09-28 |
| HN2003000048A (en) | 2003-10-28 |
| KR20040079952A (en) | 2004-09-16 |
| WO2003063837A1 (en) | 2003-08-07 |
| CN1713895A (en) | 2005-12-28 |
| IL162724A0 (en) | 2005-11-20 |
| AR038236A1 (en) | 2005-01-05 |
| BR0307190A (en) | 2004-11-03 |
| JP2005521661A (en) | 2005-07-21 |
| PL373882A1 (en) | 2005-09-19 |
| MXPA04007237A (en) | 2004-10-29 |
| NZ533283A (en) | 2006-12-22 |
| ZA200404367B (en) | 2006-05-31 |
| TW200302111A (en) | 2003-08-01 |
| EP1469836A1 (en) | 2004-10-27 |
| SV2004001467A (en) | 2004-05-07 |
| PE20030730A1 (en) | 2003-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108973T1 (en) | DRIED PREPARED COMPOSITION CONTAINING EXTRACTIVE AND TENOPHOIR DF | |
| BRPI0613754B8 (en) | compounds, ester of a compound, pharmaceutical compositions comprising the compound, method for the therapeutic and/or prophylactic treatment of diseases that are modulated by thyroid hormone analogues, and use of the compounds | |
| AR051618A1 (en) | COMPRESSED BICYCLE AND METHOD | |
| NO20064041L (en) | Substituted pyrazoline compositions, their preparation and use as drugs | |
| BRPI0707044B8 (en) | water-insoluble matrix tablet and matrix tablet manufacturing process | |
| ECSP077999A (en) | FORMULATIONS OF A MODIFIED LIBERATION BUPROPION SALT | |
| CL2015001891A1 (en) | Enclosed controlled dose dosage forms resistant to tampering; use to treat pain; and method of preparation. (divisional of the application n ° 2754-2014). | |
| ECSP099320A (en) | Tetrahydropyrrolopyrazine substituted compounds and their application in medicines | |
| NO20084065L (en) | Quick-release paracetamol tablets | |
| AR038527A1 (en) | DOSAGE FORM CONTAINING A PDE 4 INHIBITOR AS ACTIVE INGREDIENT | |
| ES2091142T3 (en) | AMILOSE RETICULATED AS A BINDER / DISGREGANT IN TABLETS. | |
| EA201691322A1 (en) | PHARMACEUTICAL COMPOSITION OF DPP-IV INHIBITOR IN COMBINATION WITH METFORMIN | |
| NO20074109L (en) | Intravenous formulations of PDE-5 inhibitors | |
| DOP2002000389A (en) | METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION OF LOW DOSE THAT HAS A DISTRIBUTION AND POWER OF THE UNIFORM DRUG | |
| AR077284A1 (en) | SOLID PHARMACEUTICAL FIXED DOSAGE COMPOSITIONS INCLUDING IRBESARTAN AND AMLODIPINE, ITS PREPARATION AND THERAPEUTIC APPLICATION | |
| CY1122114T1 (en) | N-ACETYLOCYSTEINE SWALLOWED TABLETS | |
| CO6640264A2 (en) | Combination of active loaded granules with additional assets | |
| NI200300001A (en) | Nelfinavir COMPRESSED DOSAGE AND METHOD FOR INCREASED manufacture. | |
| AR080256A1 (en) | SOLID PHARMACEUTICAL FORMULATIONS OF RAMIPRIL AND AMLODIPINO BESYLATE AND ITS PREPARATION | |
| UY27625A1 (en) | COMPRESSED NELFINAVIR OF INCREASED DOSE AND METHOD FOR MANUFACTURING IT | |
| DOP2003000567A (en) | COMPRESSED NELFINAVIR OF INCREASED DOSE AND METHOD TO MANUFACTURE IT | |
| MXPA02010828A (en) | Pharmaceutical composition in capsules comprising a non-steroidal anti-inflammatory and an opiate analgesic for handling pain. | |
| BRPI0407850A (en) | process for the manufacture of a pharmaceutical composition containing the active ingredient fenofibrate or one of its derivatives, and fenofibrate tablet or one of its derivatives | |
| TR200102802T2 (en) | High L-carnitine-alkanoyl L-carnitine granulate in the direct compression of tablets | |
| AR027058A1 (en) | REPLACED PIRROLIC BASES OF MANNICH, PROCEDURE FOR PREPARATION, MEDICATIONS CONTAINING COMPOUNDS AND USE OF THESE COMPOUNDS FOR THE PREPARATION OF MEDICINES |